Result of 2022 Annual General Meeting
Updated : 22:32
18 October 2022
Accrol Group Holdings plc
("Accrol", the "Company" or the "Group")
AIM: ACRL
Result of 2022 Annual General Meeting
Accrol, the leading independent tissue converter in the UK, announces that all of the resolutions set out in the Notice of AGM were passed by the requisite majority at the Company's AGM, held earlier today.
Details of the proxy votes received by the Company are as follows:
Resolution | For | Against | Withheld | ||
| No. of votes | % | No. of votes | % | No. of votes |
1. To receive the Annual Report and Accounts | 189,816,491 | 99.95 | 103,474 | 0.05 | 10,759 |
2. To appoint BDO as Auditor | 189,621,942 | 99.84 | 298,023 | 0.16 | 10,759 |
3. To approve the Directors' Remuneration Report | 179,946,678 | 94.75 | 9,973,287 | 5.25 | 10,759 |
4. To re-elect Simon Allport as a Director | 188,359,619 | 99.28 | 1,360,346 | 0.72 | 210,759 |
5. To authorise the Directors to allot relevant securities | 189,586,383 | 99.82 | 333,582 | 0.18 | 10,759 |
6. To authorise the Directors to allot equity securities for cash without making a pre-emptive offer to shareholders* |
189,585,650 |
99.82 |
334,315 |
0.18 |
10,759 |
*Special resolution
Notes:
1. | Proxy appointments which gave discretion to the Chairman of the AGM have been included in "For" total for the appropriate resolution. |
2. | Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution. |
3. | A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against". |
4. | The number of shares in issue on 18 October 2022 was 318,878,097 with no shares in treasury. |
5. | The full text of the resolutions passed at the AGM is available in the Notice of AGM on the Company's website: https://www.accrol.co.uk/app/uploads/2022/09/22-09-23-Accrol-Notice-of-AGM-Web-1.pdf. |
For further information, please contact: |
|
| |
Accrol Group Holdings plc | |
Dan Wright, Executive Chairman | Via Belvedere Communications |
Gareth Jenkins, Chief Executive Officer | |
Richard Newman, Chief Financial Officer | |
| |
Zeus (Nominated Adviser & Broker) |
|
Dan Bate / Jordan Warburton | Tel: +44 (0) 161 831 1512 |
Dominic King | Tel: +44 (0) 203 829 5000 |
Liberum Capital Limited (Joint Broker) | Tel: +44 (0) 20 3100 2222 |
Clayton Bush / Edward Thomas | |
Belvedere Communications Limited | |
Cat Valentine | Tel: +44 (0) 7715 769 078 |
Keeley Clarke | Tel: +44 (0) 7967 816 525 |
accrolpr@belvederepr.com |
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the £2.1bn UK retail tissue market.
For more information, please visit www.accrol.co.uk
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.